Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base-Reference-Cited by-同舟云学术

Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base

Published:2017-12-04 Issue:6 Volume:124 Page:1169-1178
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jhaveri Jaymin¹^ORCID,Liu Yuan²,Chowdhary Mudit¹³,Buchwald Zachary S.¹,Gillespie Theresa W.⁴,Olson Jeffrey J.⁵,Voloschin Alfredo D.⁶,Eaton Bree R.¹,Shu Hui-Kuo G.¹,Crocker Ian R.¹,Curran Walter J.¹,Patel Kirtesh R.¹⁷

Affiliation:

1. Department of Radiation Oncology and Winship Cancer Institute; Emory University; Atlanta Georgia

2. Biostatistics and Bioinformatics Shared Resource; Winship Cancer Institute, Emory University; Atlanta Georgia

3. Department of Radiation Oncology; Rush University Medical Center; Chicago Illinois

4. Department of Surgery and Winship Cancer Institute; Emory University; Atlanta Georgia

5. Department of Neurosurgery and Winship Cancer Institute; Emory University; Atlanta Georgia

6. Department of Hematology and Medical Oncology and Winship Cancer Institute; Emory University; Atlanta Georgia

7. Department of Therapeutic Radiology and Smilow Cancer Center; Yale School of Medicine; New Haven Connecticut

Funder

Winship Cancer Institute of Emory University

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial;Shaw;J Neurosurg.,2008

2. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma;Buckner;N Engl J Med.,2016

3. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas;Brada;Ann Oncol.,2003

4. Phase II trial of temozolomide in patients with progressive low-grade glioma;Quinn;J Clin Oncol.,2003

5. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study;Baumert;Lancet Oncol.,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ferroptosis-related risk genes on macrophage M1/M2 polarization and prognosis in glioblastoma;Frontiers in Cellular Neuroscience;2024-01-10

2. An integrated bioinformatic investigation of focal adhesion-related genes in glioma followed by preliminary validation of COL1A2 in tumorigenesis;Aging;2023-06-22

3. Ferroptosis-related NFE2L2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in Glioma;Cell Biochemistry and Biophysics;2023-01-11

4. Automatic 1p/19q co-deletion identification of gliomas by MRI using deep learning U-net network;Computers and Electrical Engineering;2023-01

5. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma;Frontiers in Immunology;2022-10-06